Back
Schwab Emerging Markets Equity ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
47
SCHE
Schwab Emerging Markets Equity ETF
Last Price:
$32.42
Seasonality Move:
1.32%
Sell
23
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
47
Schwab Emerging Markets Equity ETF (SCHE)
is a Sell
Is Schwab Emerging Markets Equity ETF a Buy, Sell or Hold?
-
The current Schwab Emerging Markets Equity ETF [SCHE] share price is $32.41. The Score for SCHE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
SCHE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCHE Stock Price Chart
What is Schwab Emerging Markets Equity ETF's stock price today?
-
The Schwab Emerging Markets Equity ETF share price today is $32.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCHE is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $33.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.
SCHE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.04 | Buy |
| Relative Strength Index (14 RSI): | 41.07 | Sell |
| Chaikin Money Flow: | -274844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.45 - 33.59) | Sell |
| Bollinger Bands (100): | (31.7 - 33.82) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.24 | Buy |
| Relative Strength Index (14 RSI): | 45.54 | Sell |
| Chaikin Money Flow: | 579058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Sell |
| Bollinger Bands (100): | (29.19 - 34.19) | Buy |
SCHE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.38 | Buy |
| 20-day SMA: | 32.95 | Sell |
| 50-day SMA: | 33.38 | Sell |
| 200-day SMA: | 30.74 | Buy |
| 8-day EMA: | 17.02 | Buy |
| 20-day EMA: | 8.33 | Buy |
| 50-day EMA: | 3.63 | Buy |
| 200-day EMA: | 0.95 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.82 | Sell |
| 20-day SMA: | 34.8 | Sell |
| 50-day SMA: | 33.74 | Sell |
| 200-day SMA: | 33.57 | Sell |
| 8-day EMA: | 17.59 | Buy |
| 20-day EMA: | 8.61 | Buy |
| 50-day EMA: | 3.75 | Buy |
| 200-day EMA: | 0.98 | Buy |
Schwab Emerging Markets Equity ETF Earnings Growth & SCHE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Schwab Emerging Markets Equity ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||